Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 21, 2018 - Issue 3
425
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

The effect of 1, 25(OH)2 D3 (calcitriol) alone and in combination with all-trans retinoic acid on ROR-γt, IL-17, TGF-β, and FOXP3 gene expression in experimental autoimmune encephalomyelitis

, , , , , , ORCID Icon & show all

References

  • Passos GRD, Sato DK, Becker J, Fujihara K. Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications. Mediators Inflamm 2016;2016:5314541. doi: 10.1155/2016/5314541
  • Mohammadzadeh Honarvar N, Harirchian MH, Abdolahi M, Abedi E, Bitarafan S, Koohdani F, et al. Retinyl palmitate supplementation modulates T-bet and interferon gamma gene expression in multiple sclerosis patients. J Mol Neurosci 2016;59:360–5. doi: 10.1007/s12031-016-0747-2
  • Buc M. Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis. Mediators Inflamm 2013;2013:963748. doi: 10.1155/2013/963748
  • Abdolahi M, Yavari P, Honarvar NM, Bitarafan S, Mahmoudi M, Saboor-Yaraghi AA. Molecular mechanisms of the action of vitamin A in Th17/Treg axis in multiple sclerosis. J Mol Neurosci 2015;57:605–13. doi: 10.1007/s12031-015-0643-1
  • Chen G, Shannon M. Transcription factors and Th17 cell development in experimental autoimmune encephalomyelitis. Crit Rev Immunol 2013;33:165–82. doi: 10.1615/CritRevImmunol.2013006959
  • Zambrano-Zaragoza JF, Romo-Martínez EJ, Durán-Avelar MdJ, García-Magallanes N, Vibanco-Pérez N. Th17 cells in autoimmune and infectious diseases. Int J Inflam 2014;2014:651503. doi: 10.1155/2014/651503
  • Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485–517. doi: 10.1146/annurev.immunol.021908.132710
  • Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19:652–7. doi: 10.1016/j.coi.2007.07.020
  • Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218–22. doi: 10.1172/JCI28508
  • Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008;31:252–6. doi: 10.1016/j.jaut.2008.04.017
  • Saboor-Yaraghi AA, Harirchian MH, Mohammadzadeh Honarvar N, Bitarafan S, Abdolahi M, Siassi F, et al. The effect of vitamin A supplementation on FoxP3 and TGF-beta gene expression in Avonex-treated multiple sclerosis patients. J Mol Neurosci 2015;56:608–12. doi: 10.1007/s12031-015-0549-y
  • Hofstetter H, Gold R, Hartung HP. Th17 cells in MS and experimental autoimmune encephalomyelitis. Int MS J 2009;16:12–8.
  • Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13:1173–5. doi: 10.1038/nm1651
  • Fainardi E, Castellazzi M, Bellini T, Manfrinato MC, Baldi E, Casetta I, et al. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 2006;12:294–301. doi: 10.1191/135248506ms1274oa
  • Yong VW, Zabad RK, Agrawal S, Goncalves Dasilva A, Metz LM. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 2007;259:79–84. doi: 10.1016/j.jns.2006.11.021
  • Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010;159:109–19. doi: 10.1111/j.1365-2249.2009.04037.x
  • Li H, Nourbakhsh B, Ciric B, Zhang GX, Rostami A. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J Immunol 2010;185:4095–100. doi: 10.4049/jimmunol.1000986
  • Kim CH. Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol 2008;2008:416910. doi: 10.1155/2008/416910
  • Cassani B, Villablanca EJ, De Calisto J, Wang S, Mora JR. Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol Aspects Med 2012;33:63–76. doi: 10.1016/j.mam.2011.11.001
  • Lowther DE, Hafler DA. Regulatory T cells in the central nervous system. Immunol Rev 2012;248:156–69. doi: 10.1111/j.1600-065X.2012.01130.x
  • Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 2011;74:1–13. doi: 10.1111/j.1365-3083.2011.02536.x
  • Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, et al. Inflammation-driven reprogramming of CD4+Foxp3+regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PloS One 2012;7:e35572. doi: 10.1371/journal.pone.0035572
  • Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N. Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes. Clin Exp Immunol 2013;174:302–17.
  • Chang J, Thangamani S, Kim MH, Ulrich B, Morris SM, Jr., Kim CH. Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation. Eur J Immunol 2013;43:967–78. doi: 10.1002/eji.201242772
  • Mohammadzadeh Honarvar N, Harirchian MH, Koohdani F, Siassi F, Abdolahi M, Bitarafan S, et al. The effect of vitamin A supplementation on retinoic acid-related orphan receptor gammat (RORgammat) and interleukin-17 (IL-17) gene expression in Avonex-treated multiple sclerotic patients. J Mol Neurosci 2013;51:749–53. doi: 10.1007/s12031-013-0058-9
  • Chang J-H, Cha H-R, Lee D-S, Seo KY, Kweon M-N. 1,25-dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 2010;5:e12925. doi: 10.1371/journal.pone.0012925
  • Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol 2012;72:234–40. doi: 10.1002/ana.23591
  • Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008;52:1949–56. doi: 10.1016/j.jacc.2008.08.050
  • Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, et al. Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up. J Gerontol A Biol Sci Med Sci 2012;67:1205–11. doi: 10.1093/gerona/gls107
  • DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC. Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 2013;39:458–84. doi: 10.1111/nan.12020
  • Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000;374:334–8. doi: 10.1006/abbi.1999.1605
  • Cippitelli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 1998;28:3017–30. doi: 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.0.CO;2-6
  • Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003;102:3314–6. doi: 10.1182/blood-2002-11-3521
  • Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Sanvito F, et al. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. J Immunol 2006;177:8504–11. doi: 10.4049/jimmunol.177.12.8504
  • Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM, et al. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 2011;286:997–1004. doi: 10.1074/jbc.M110.163790
  • Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:1294–6. doi: 10.1136/jnnp.2004.056499
  • Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest 2014;43:54–68. doi: 10.3109/08820139.2013.825269
  • Society for Neuroscience. Policies on the use of animals and humans in neuroscience research 2016. Available from: https://www.sfn.org/advocacy/policy-positions/policies-on-the-use-of-animals-and-humans-in-research.
  • Nashold FE, Nelson CD, Brown LM, Hayes CE. One calcitriol dose transiently increases Helios+FoxP3+T cells and ameliorates autoimmune demyelinating disease. J Neuroimmunol 2013;263:64–74. doi: 10.1016/j.jneuroim.2013.07.016
  • Nashold FE, Hoag KA, Goverman J, Hayes CE. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 2001;119:16–29. doi: 10.1016/S0165-5728(01)00360-5
  • Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 2011;31:3653–69. doi: 10.1128/MCB.05020-11
  • Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, et al. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317:256–60. doi: 10.1126/science.1145697
  • Keino H, Watanabe T, Sato Y, Okada AA. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis. Br J Ophthalmol 2010;94:802–7. doi: 10.1136/bjo.2009.171314
  • Cantorna MT, Hayes CE, DeLuca HF. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998;128:68–72.
  • Camacho LH, Soignet SL, Chanel S, Ho R, Heller G, Scheinberg DA, et al. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol 2000;18:2620–5. doi: 10.1200/JCO.2000.18.13.2620
  • Han D, Xi L, Fan E, Li Y, Zhang L. Expression of the Foxp3 gene in spleen mononuclear cells of a mouse model with allergic rhinitis. ORL J Otorhinolaryngol Relat Spec 2009;71:317–22. doi: 10.1159/000267304
  • Primer designing tool – NCBI. Available from: http://www.ncbi.nlm.nih.gov/tools/primer-blast/.
  • Zhen C, Feng X, Li Z, Wang Y, Li B, Li L, et al. Suppression of murine experimental autoimmune encephalomyelitis development by 1,25-dihydroxyvitamin D3 with autophagy modulation. J Neuroimmunol 2015;280:1–7. doi: 10.1016/j.jneuroim.2015.01.012
  • Li B, Baylink DJ, Deb C, Zannetti C, Rajaallah F, Xing W, et al. 1,25-dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS One 2013;8:e58808. doi: 10.1371/journal.pone.0058808
  • Chang SH, Chung Y, Dong C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem 2010;285:38751–5. doi: 10.1074/jbc.C110.185777
  • Ivanov, II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006;126:1121–33. doi: 10.1016/j.cell.2006.07.035
  • Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 1995;154:450–8.
  • Kwok SK, Park MK, Cho ML, Oh HJ, Park EM, Lee DG, et al. Retinoic acid attenuates rheumatoid inflammation in mice. J Immunol 2012;189:1062–71. doi: 10.4049/jimmunol.1102706
  • Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008;181:2277–84. doi: 10.4049/jimmunol.181.4.2277
  • Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS, et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 2009;182:4624–32. doi: 10.4049/jimmunol.0801543
  • Spanier JA, Nashold FE, Olson JK, Hayes CE. The IFNG gene is essential for Vdr gene expression and vitamin D(3)-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model. J Immunol 2012;189:3188–97. doi: 10.4049/jimmunol.1102925
  • Liu ZM, Wang KP, Ma J, Guo Zheng S. The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells. Cell Mol Immunol 2015;12:553–7. doi: 10.1038/cmi.2014.133
  • Lu L, Ma J, Li Z, Lan Q, Chen M, Liu Y, et al. All-trans retinoic acid promotes TGF-beta-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS One 2011;6:e24590. doi: 10.1371/journal.pone.0024590
  • Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q, et al. Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA 2014;111:E3432–40. doi: 10.1073/pnas.1408780111
  • Bai A, Lu N, Guo Y, Liu Z, Chen J, Peng Z. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol 2009;86:959–69. doi: 10.1189/jlb.0109006
  • Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Diabetes 2009;58:146–55. doi: 10.2337/db08-1154
  • Zabransky DJ, Nirschl CJ, Durham NM, Park BV, Ceccato CM, Bruno TC, et al. Phenotypic and functional properties of Helios+ regulatory T cells. PLoS One 2012;7:e34547. doi: 10.1371/journal.pone.0034547
  • Kang SW, Kim SH, Lee N, Lee WW, Hwang KA, Shin MS, et al. 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J Immunol 2012;188:5276–82. doi: 10.4049/jimmunol.1101211
  • Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008;9:194–202. doi: 10.1038/ni1549

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.